Gain Therapeutics Inc Financial Flexibility Index
Gain Therapeutics Inc financial flexibility index. Gain Therapeutics Inc (GANX) has a Financial Flexibility Index of -1.09x as of December 2025. Free cash flow of $-4.62 Million (operating CF $-4.62 Million minus capex $3.00) represents -1% of total liabilities ($4.25 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Gain Therapeutics Inc (2018–2025)
Financial flexibility index of Gain Therapeutics Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Gain Therapeutics Inc across 8 annual periods. Explore Gain Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Gain Therapeutics Inc Financial Flexibility Index by Year (2018–2025)
Gain Therapeutics Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Gain Therapeutics Inc. For the full cash flow conversion analysis, see GANX cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.34x | $-18.47 Million | $-18.47 Million | $4.25 Million | ▼ -10.2% |
| 2024 | -3.94x | $-18.85 Million | $-18.87 Million | $4.78 Million | ▼ -26.1% |
| 2023 | -3.13x | $-18.85 Million | $-18.87 Million | $6.03 Million | ▼ -12.0% |
| 2022 | -2.79x | $-14.57 Million | $-14.69 Million | $5.22 Million | ▲ +5.2% |
| 2021 | -2.94x | $-12.27 Million | $-12.37 Million | $4.17 Million | ▼ -211.2% |
| 2020 | -0.95x | $-3.22 Million | $-3.24 Million | $3.40 Million | ▲ +43.4% |
| 2019 | -1.67x | $-1.85 Million | $-1.87 Million | $1.11 Million | ▼ -299.8% |
| 2018 | -0.42x | $-736.53K | $-744.51K | $1.76 Million | — |